Compounds > ciprofloxacin

ciprofloxacin and paromomycin

ciprofloxacin has been researched along with paromomycin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blyn, L; He, Y; Ranken, R; Risen, L; Robinson, D; Sheng, S; Swayze, EE; Wu, B; Yang, J1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Dieckmann, S; Harms, G; Ignatius, R; Marn, H; Schürmann, M; Tannich, E1

Reviews

1 review(s) available for ciprofloxacin and paromomycin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for ciprofloxacin and paromomycin

ArticleYear
2-piperidin-4-yl-benzimidazoles with broad spectrum antibacterial activities.
    Bioorganic & medicinal chemistry letters, 2003, Oct-06, Volume: 13, Issue:19

    Topics: Anti-Bacterial Agents; Benzimidazoles; Enterococcus; Microbial Sensitivity Tests; Piperidines

2003
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Amoebic liver abscess with negative serologic markers for Entamoeba histolytica: mind the gap!
    Infection, 2012, Volume: 40, Issue:1

    Topics: Administration, Oral; Adult; Agglutination Tests; Antigens, Protozoan; Antiprotozoal Agents; Ciprofloxacin; Entamoeba histolytica; Entamoebiasis; Fluorescent Antibody Technique; Germany; Humans; Immunoenzyme Techniques; Liver; Liver Abscess, Amebic; Male; Metronidazole; Paromomycin; Ultrasonography

2012